1-3 of 3
Uwe Rix, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pacritinib (PAC) Synergistically Potentiates Azacitidine (5AZA) Cytotoxicity in Chronic Myelomonocytic Leukemia (CMML)

Yan Ma, MD, Lily Remsing Rix, Qing Zhang, MD, Maria E. Balasis, Rami S. Komrokji, MD, Uwe Rix, PhD, Alan F. List, MD, Eric Padron, MD
Journal: Blood
Blood (2015) 126 (23): 1658.
https://doi.org/10.1182/blood.V126.23.1658.1658
Published: 2015
Journal Articles

Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome+ CML

Emir Hadzijusufovic, DVM, Karin Albrecht-Schgoer, PhD, Kilian Huber, PhD, Florian Grebien, PhD, Gregor Eisenwort, MD PhD, Wilfried Schgoer, MD PhD, Christoph Kaun, Susanne Herndlhofer, Markus Theurl, PhD, Sabine Cerny-Reiterer, DVM, Gregor Hoermann, MD PhD, Wolfgang R Sperr, MD, Uwe Rix, PhD, Irina Sadovnik, MSc, Bernd Jilma, MD, Gerit Holger Schernthaner, MD, Johann Wojta, PhD, Dominik Wolf, MD, Giulio Superti-Furga, PhD, Rudolf Kirchmair, MD, Peter Valent, MD
Journal: Blood
Blood (2014) 124 (21): 1800.
https://doi.org/10.1182/blood.V124.21.1800.1800
Published: 2014
Journal Articles

Systematic Profiling and Novel Targets of the Bcr-Abl Kinase Inhibitors Imatinib, Nilotinib and Dasatinib.

Oliver Hantschel, PhD, Uwe Rix, PhD, Tilmann Buerckstuemmer, PhD, Uwe Schmidt, PhD, Michael Kneidinger, MD, Keiryn L. Bennett, PhD, Ines Kaupe, BSc, Wilfried Ellmeier, PhD, Peter Valent, MD, Giulio Superti-Furga, PhD
Journal: Blood
Blood (2007) 110 (11): 4542.
https://doi.org/10.1182/blood.V110.11.4542.4542
Published: 2007